Insider · CIK 0001572451
David P Bonita
directorowner
Files at PRLD (Prelude Therapeutics Inc), IMA (ImageneBio, Inc.), THRD (Third Harmonic Bio, Inc.). First filing Jul 30, 2025, latest Jul 30, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$2.5M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | ImageneBio, Inc. | $2.5M 83,611 shares | +41% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | THRD Third Harmonic Bio, Inc. | JOther Common Stock | -5,779,071 | - | - | 0 | Aug 14, 2025 |
| Aug 11, 2025 | THRD Third Harmonic Bio, Inc. | JOther Stock Optionderivative | -43,584 | $0.00 | $0 | 0 | Aug 14, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | MOption exercise Common Stock | +379 | - | - | 379 | Jul 30, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +83,611 | $29.90 | $2.5M | 287,885 | Jul 30, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | MOption exercise Stock Option (right to buy)derivative | -17,520 | $0.00 | $0 | 0 | Jul 30, 2025 |
| Jun 12, 2025 | PRLD Prelude Therapeutics Inc | AGrant or award Director Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.